HLA-DR4 (DR4) is an HLA-DR serotype that recognizes the DRB1*04 gene products. The DR4 serogroup is large and has a number of moderate frequency alleles spread over large regions of the world.
The serological identification of DR4 is good. The serology of DRB1*04:17 to *04:60 is unknown.
DR4 is associated with extraarticularrheumatoid arthritis, hydralazine-induced female systemic lupus erythematosus, pemphigoid gestationis,pemphigus foliaceus, obstructive hypertrophic cardiomyopathy, IgA nephropathy, 'shared syndrome'-systemic sclerosis/rheumatoid arthritis and polymyalgia rheumatica.
DRB1*04 is associated with increased risk for alopecia areata.
DRB1*04:01 is associated with multiple sclerosis, rheumatoid arthritis, type 1 diabetes, lyme disease induced arthritis
DRB1*04:02: drug-triggered/idiopathic pemphigus vulgaris, type 1 diabetes, SLE associated anti-cardiolipin and anti-β2 glycoprotein I
DRB1*04:03: polycystic ovary syndrome, SLE associated anti-cardiolipin and anti-β2 glycoprotein I
HLA may refer to:
Coordinates: 36°23′15″N 127°21′59″E / 36.38753°N 127.36650°E / 36.38753; 127.36650 (HLA time signal antenna) HLA is a time signal radio station in Daejeon, South Korea, operated by the Korea Research Institute of Standards and Science. Established on November 24, 1984, it transmits a 2 kW signal on 5 MHz (±0.01 Hz). Originally only transmitted for 7 hours per day (01:00–08:00), 5 days per week (M–F), it is continuous as of 2011, There are over 100 users of the signal in Korea.
It broadcasts a time signal similar to that of the WWV and WWVH stations with which it shares a frequency: